To include your compound in the COVID-19 Resource Center, submit it here.

Drug platforms

TECHNOLOGY: Gene therapy

An engineered Cas9 mutant with broad PAM compatibility could enable CRISPR-based gene editing of

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE